are factors that change with malignancy and enable detection. Given its ability to differentiate subtle structural detail, IOUS has been used successfully to improve delineation of tumor margins and volumes. 3, 6, 9, 10, 18, 19 It can detect inhomogeneous echogenic areas of diffuse necrosis, hemorrhage, and cystic components of tumors, which are details often missed in traditional imaging studies. 6 In comparison with CT and MRI, IOUS has proven to be more accurate in the differentiation between fluid-filled cystic and necrotic components of tumors. 19 Most important is that this technique enables the surgeon to follow his or her progression through a tumor excision, providing information such as localization, margin delineation, and extent of tumor remaining in real-time dimensions of brain shift. 18 As IOUS increasingly becomes incorporated into the neurosurgical armamentarium, its efficacy in determining the extent of tumor resection has been examined in populations of adults who have undergone neurosurgery. Unsgaard et al. 18 compared the efficacy of using IOUS to using the naked eye. Once the surgeon had achieved grosstotal resection, one "last" IOUS scan revealed residual tumor in 53% of the patients, consequently leading to further tumor removal and a greater extent of resection. Hammoud et al. 7 compared the final IOUS scan to the postoperative MRI scan. In that study, of the 18 patients who had not had previous therapy, all of them had tumors with well-defined margins, and IOUS accurately determined the extent of resection. Chacko et al. 2 performed a similar study that compared IOUS to postoperative MRI and also included histological samples from the brain-tumor interface to determine the sensitivity of IOUS. The tumor margins were well defined in 71.4% of the patients, all of whom had not had previous treatment. In tissue samples sent from sites at which IOUS revealed gross-total resection, 15 (88.2%) of 17 indeed confirmed negative margins, thus suggesting an important new indication for IOUS. 2 Furthermore, with improvements in ultrasonographic technology, IOUS may be used as an alternative to intraoperative MRI for determining the extent of tumor resection in real time. Using IOUS provides the advantage of lower cost, and IOUS is more readily available for general application in institutions that do not have intraoperative MRI capability. In addition, introducing the IOUS probe into the operative field in a sterile manner is simpler and less time-consuming than placing the operative field within the parameters of an MRI machine.
Up to now, only 2 existing studies have explored the use of IOUS in determining the extent of tumor resection in pediatric patients. 5, 17 The first study achieved an 82% overall gross-total resection rate and a 94% intended gross-total resection rate when excluding cases in which tumor was knowingly left behind. 5 The second study included 22 cases in which complete resection was determined by the surgeon using IOUS, and only 1 case was later refuted by the neuroradiologist, who compared IOUS with the postoperative MRI. The authors emphasized the potential benefit of IOUS with tumor resection in younger patients and encouraged further investigation with more studies. 17 Our study primarily aimed to evaluate the correlation of extent of resection between IOUS and postoperative MRI to provide further support for the role of IOUS in enhancing tumor surgery and negative margins. In this case series, we measured the correlation of extent of resection, negative predictive value, and sensitivity of IOUS and compared them with those of MRI.
Methods
This study consisted of a retrospective chart review of pediatric patients with CNS tumors treated surgically by a single pediatric neurosurgeon between August 2009 and September 2015 at Albany Medical Center in Albany, New York. All data were obtained from electronic medical records securely maintained in a central database in the hospital. Included were patients who were aged ≤ 21 years, who underwent brain or spinal tumor resection, and who underwent IOUS during tumor resection and postoperative MRI with and without contrast within 1 week of surgery. Baseline characteristics were collected, as were clinical outcomes. The Albany Medical Center Committee on Research Involving Human Subjects approved this study.
First, a list of subjects was compiled from the pediatric neurosurgeon's billing list by identifying patients who had undergone resection of a brain or spinal cord tumor. For each patient on this list, the operative note, official pathology report, and official radiology report for the postoperative MRI were examined. Postoperative MRI with and without contrast was performed within 1 week of surgery, and the images were read by a board-certified radiologist. If postoperative changes obscured the final readout for residual tumor detection, the next postoperative MRI (performed within 3 months after surgery, per department policy) readout was examined. This second postoperative MRI was inspected in approximately half of the cases to improve accuracy of the results. The IOUS data were obtained from the operative report. This information was recorded, and the sensitivity and negative predictive values of IOUS were calculated by using the online version of MedCalc (www.medcalc.org). All other statistical analyses were performed with IBM SPSS Statistics for Windows, version 21.0.
technique
All patients underwent preoperative neuronavigational MRI (Philips) with and without contrast. At the time of surgery, each patient was placed in a Mayfield pin head holder and secured to preferentially expose the intended surgical site. Brainlab was used for neuronavigation, and the preoperative images were registered to the patient. A craniotomy was performed, and once the dura mater was exposed, the surgical site was filled with a sterile saline solution to facilitate appropriate transduction of the acoustic beam between the IOUS probe and the dura. The sterile ultrasound probe (Hitachi Aloka Medical, Ltd., ProSound Alpha 5sx or Alpha7) was placed to define the tumor location and boundary. The relative location of the tumor was defined by scanning the surgical site for anatomical landmarks such as the ventricles or falx. Intraoperative ultrasound was conducted periodically throughout to assess the progression and appropriate trajectory of resection.
Once the tumor appeared completely resected by gross inspection, the ultrasound machine was brought back in for a final scan. If IOUS detected remnant tumor, resection was carefully continued until the final IOUS scan yielded a negative evaluation. Residual tumor in 11 patients was known at the time of surgery or even predicted during surgical planning because the tumor encroached on anatomically sensitive regions (such as the thalamus or brainstem). The use of IOUS became more valuable throughout the operation because of its ability to provide visualization in real time of relative tumor volume and location in the dynamic environment of resection.
In cases of spinal cord tumor, IOUS began once the laminectomy was performed and with the same technique as that for cases of cranial tumor but with a spine probe. 
results
A total of 62 patients met the inclusion criteria during the specified study period, including both newly diagnosed (n = 54) and recurrent (n = 8) tumors. Of the 62 patients, 33 were male and 29 were female. The mean age of the study patients was 10.0 years (range 3 months to 21 years).
The IOUS results correlated to a very significant degree with postoperative MRI results (ϕ = 0.726; p = 0.000000011). The calculated negative predictive value of IOUS was 86.3% (95% CI 73.7%-94.3%), and the sensitivity was 61.1% (95% CI 35.8%-82.7%) (refer to Table 1 for a 2 × 2 diagnostic evaluation table). The IOUS and postoperative MRI results are further broken down according to tumor pathology in Table 2 .
Of 62 patients, 44 (71%) demonstrated negative residual tumor on both IOUS and postoperative MRI. Eleven (18%) patients showed residual tumor on both IOUS and postoperative MRI as a result of the tumor being located in an anatomically delicate area, whereas 7 patients (11%) had a false-negative result (negative residual tumor on IOUS, positive residual tumor on MRI). These results exemplify a 71% overall gross-total resection rate and an 80% intended gross-total resection rate with the use of IOUS (i.e., excluding cases performed only for debulking purposes). Of the 7 false-negative tumors, 5 (71%) were in the parietal lobe, whereas only 2 were in other areas of the brain (1 thalamic mass and 1 intraventricular mass). Overall, the study included 11 parietal lobe tumors, 5 (45%) of which had a false-negative result. This is represented graphically in Fig. 3 . The overall results are broken down further according to tumor location in Table 3 . The false-negatives were distributed relatively evenly over the 7 years of the study, and no predominance in the beginning years of the surgeon's career was found. In addition, false-negative tumors varied from WHO Grade I to WHO Grade IV with no predilection for low-or high-grade tumors (shown in Table 4 ). Nineteen percent of the patients underwent additional surgeries for tumor resection, often because of recurrent tumor growth.
Discussion
CNS tumors remain the primary cause of death resulting from cancer in children aged 0-14 years, 11, 14 and maximal tumor resection has significant clinical implications for improving outcomes in the pediatric population. 12, 13, 15, 16 When determination for the extent of resection is being made, the effect on overall prognosis, degree of neurological morbidity from the tumor, and risk of neurological morbidity from surgery relative to the baseline neurological status must be taken into consideration. In In our case series, we found a respectable negative predictive value of 86.3% with the inclusion of multiple tumor pathologies located throughout the CNS. Across the diverse surgical cases considered in this study, a 71% overall gross-total resection rate was achieved. Excluding cases in which tumors were intended only to be debulked given their anatomical location, the study reflected an 80% intended gross-total resection rate with the use of IOUS. Using IOUS did not confer any identifiable complications and contributed minimal additional time to surgery. The results of our study stand in congruence with those of previously reported investigations, and we contribute more generalizability across tumor types and locations. El Beltagy et al. 5 recently described the role of IOUS in pediatric CNS tumor resection. Using a conventional 2D 6.5-MHz probe, they concluded that the technique was useful for delineating the border between tumor and healthy brain tissue and for detecting remnant tumor that otherwise would have been missed. This study achieved an 82% overall gross-total resection rate and 94% intended gross-total resection rate in a smaller, less representative cohort of 22 pediatric patients. Ulrich et al. 17 replicated this research and stated that IOUS enabled more effective differentiation between tumor and healthy brain tissue.
Periodic IOUS throughout tumor surgery can assist the surgeon in achieving better resection margins in individual cases. The technique provides immediate information about tumor volume and location as resection proceeds under conditions of CSF efflux and brain shift. We can continuously adjust our plan accordingly to the point of gross-total resection. However, we knowingly leave remnant tumor behind in specific cases, depending on the gravity of the risk/benefit ratio. The ability to evaluate extent of resection and predict what the postoperative MRI will show is a powerful tool, just as meaningful as the ability to achieve negative margins in favorable cases. The highly significant correlation between IOUS and postoperative MRI lends confidence to the use of IOUS as a valuable tool in tumor resection.
Other neuronavigational modalities can guide tumor surgery, but intraoperative CT or MRI poses greater complexities. These intraoperative modalities significantly lengthen operating-room time, require additional staff to run the scanners, increase the risk of breaks in sterility, and have much higher overhead and running costs. Contrast is required for tissue demarcation, and ionizing radiation is emitted in the case of intraoperative CT. However, intraoperative MRI provides the advantage of eliminating the need for postoperative imaging and a second anesthetic-requiring scan. Intraoperative ultrasound offers a relatively simple means for surgical guidance with favorable risk/benefit and cost/benefit ratios.
Despite the high correlation of IOUS with the postoperative MRI in our case series, we do not propose that IOUS should supplant postoperative MRI. Postoperative MRI is necessary in all tumor cases, whether for a new baseline for surveillance imaging, radiation treatment planning, or both. We emphasize the utility of IOUS as an intraoperative tool that can provide information and guidance in real time. Using IOUS can certainly enhance the potential for greater rates of gross-total resection by providing intraoperative information, and the true benefit of IOUS is to show us how much tumor remains, if any, before making the decision to end the surgery based on the benefit/risk ratio.
In our practice, IOUS is used routinely in adult and pediatric patients with a CNS tumor, but we acknowledge that IOUS has some limitations. A practical limitation is user dependency. As with many aspects of neurosurgery, user dependency is subject to a steep learning curve, but this limitation can be overcome readily with persistent use and instruction by an experienced neurosurgeon. Some institutions call a neuroradiologist into the operating room to interpret IOUS images. In this particular series, false-negative tumors were distributed fairly evenly over the 7 years and did not suggest user dependency to be a limiting factor in the study. IOUS requires a high-end ultrasound machine with a combined 5-to 7-MHz sector transducer and a 7-to 12-MHz linear transducer for ideal neuroanatomical imaging. 4 Although the image quality of ultrasound falls short of the exquisite detail of MRI, with a high-frequency linear transducer, one can differentiate the low-echogenic cortical ribbon from the brighter echogenicity of the subcortical white matter, and color Doppler sonography can easily evaluate tumor vascularity. 4 Insonation depth can also be sequentially reduced on tumor examination to improve imaging with greater detail, 4 and picture quality continues to improve with technological advances. Recent work with contrast-enhanced ultrasonography showed promising results for improving the visualization of tumors with ill-defined borders and differentiation between tumor and surrounding edematous brain tissue, which are 2 well-recognized limitations of IOUS. 4 Another limitation of IOUS manifests in circumstances of recurrent tumors presenting for repeat resection or tumors that were irradiated previously. 10 Gliosis affects the composition of brain matter and, thus, its acoustical propagation of sound. 8 In a study by Hammoud et al., 7 tumors were well localized in only 62% of the 13 patients who had undergone radiation therapy previously, and the extent of tumor resection was poorly defined. Similarly, Chacko et al. 2 also reported ill-defined margins in patients with a previous history of radiation treatment.
Of the 7 patients in this study with a false-negative tumor, 2 had undergone previous surgery or radiation therapy for their CNS tumor. Another 3 of these 7 patients presented with a later-stage, more aggressive pathology. Last, 1 patient's tumor was diagnosed as tuberous sclerosis, which distorted the normal anatomy. Table 3 outlines the characteristics of these 7 subjects, including tumor type, location, and previous therapy. From this study, we cannot make significant comments on the correlation between IOUS and postoperative MRI based on tumor pathology or location. The diversity of pathology types limits the N value for any 1 classification, which makes any statistical analysis powerless. Qualitative observation reveals the parietal location to be more challenging in the evaluation of extent of tumor resection with IOUS, and there was a preponderance of false-negative results in this region.
conclusions
The use of IOUS may play an important role in achieving a better extent of resection and improved clinical outcomes with minimal additional operating-room time and no identified additional risk and at low cost. The aid of IOUS enables us to make moment-to-moment decisions and adjustments to have a real impact on pediatric patients. Technological advances will improve image quality and enhance the role of IOUS in pediatric CNS tumor surgery, but we support the continued use of IOUS in the meantime given its favorable benefit/risk ratio. 
